Want to see VATE full AI Analyst Report?
INNOVATE Corp (VATE) AI Stock Analysis
INNOVATE Corp
(NYSE:VATE)
INNOVATE Corp's overall score reflects a transitional phase characterized by highly positive strategic asset sales and aggressive debt reduction that have dramatically improved its balance sheet and cash flow. However, these structural improvements are heavily offset by ongoing net unprofitability, an unfavorable valuation, and strong bearish technical momentum.
INNOVATE Corp (VATE) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $73.39M
- Dividend Yield
- ―
- Average Volume (3M)
- 374.20K
- Price to Earnings (P/E)
- -2.9
- Beta (1Y)
- 2.56
- Revenue Growth
- 52.38%
- EPS Growth
- 70.10%
- Country
- US
- Employees
- 3,663
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Engineering & Construction
INNOVATE Corp Business Overview & Revenue Model
Company Description
INNOVATE Corp. (VATE), a New York-based entity founded in 1994 and previously known as HC2 Holdings, Inc. until its name change in September 2021, manages a diverse range of subsidiaries operating within the infrastructure, life sciences, and spectru...
How the Company Makes Money
INNOVATE Corp makes money primarily through revenue generated by its operating subsidiaries, which sell their products and services to customers in their respective end markets. Cash flow is then used to fund operations at the subsidiary level and su...
INNOVATE Corp Earnings Call Summary
The call reflects a predominantly positive operational story driven by a strong Infrastructure / DBMG performance that delivered outsized revenue (up 33% consolidated) and adjusted EBITDA improvement. Significant regulatory and clinical milestones at MediBeacon and international growth at R2 are constructive. However, meaningful challenges remain in smaller but important areas: Life Sciences revenues fell sharply (-48.4%), R2 is seeking external capital, Spectrum experienced advertising weakness and cancellations, DBMG saw ~140 bps gross margin compression, and consolidated debt increased due to PIK interest. Overall, the positive momentum in the company’s largest revenue driver and improved overall profitability outweighs the segment‑level headwinds, but capital structure and segment weaknesses warrant continued attention.
Q1-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management’s guidance was largely qualitative and focused on improving 2026 visibility, continued Infrastructure momentum and pipeline-driven backlog growth, while they work on capital‑structure alternatives; key Q1 metrics referenced include consolidated revenue $364.8M (up 33% YoY), total adjusted EBITDA $19.7M (vs. $7.2M), net loss $17.2M or $1.29 per diluted share (vs. $24.8M, $1.89), cash $134.6M, and total debt $699M (up $11.8M); Infrastructure/DBMG exited Q1 with revenue $357.9M (up 35.1% YoY), adjusted EBITDA $23.0M, gross margin 14.2% (≈140 bps compression YoY), reported backlog $1.6B and adjusted backlog $1.8B; Life Sciences/R2 reported Q1 revenue $1.6M (down 48.4%), total demand $2.2M and a backlog of ≈160 systems (~$2M) and is seeking external capital; Spectrum had Q1 revenue $5.3M and adjusted EBITDA $0.7M but cited near‑term softness offset by regulatory tailwinds (applications for >60 LPT licenses, >25 Class A relocations) and potential commercial opportunities.
INNOVATE Corp Financial Statement Overview
Summary
The company exhibits excellent free cash flow generation and has successfully completed massive deleveraging to restore positive equity. However, persistent bottom-line net losses remain a central weakness constraining the overall financial score.
Income Statement
55NeutralBalance Sheet
65PositiveCash Flow
85Very Positive| Breakdown | TTM | Dec 2025 | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.52B | 1.25B | 1.11B | 1.42B | 1.64B | 1.21B |
| Gross Profit | 228.70M | 182.20M | 208.80M | 216.00M | 221.40M | 183.70M |
| EBITDA | 114.30M | 57.90M | 74.00M | 63.10M | 62.80M | 31.80M |
| Net Income | -22.40M | -60.60M | -34.60M | -35.20M | -35.90M | -227.50M |
Balance Sheet | ||||||
| Total Assets | 1.01B | 950.10M | 891.10M | 1.04B | 1.15B | 1.08B |
| Cash, Cash Equivalents and Short-Term Investments | 87.80M | 112.10M | 48.80M | 80.80M | 80.40M | 45.50M |
| Total Debt | 682.40M | 717.50M | 719.20M | 771.90M | 785.30M | 684.80M |
| Total Liabilities | 1.23B | 1.17B | 1.05B | 1.20B | 1.18B | 1.09B |
| Stockholders Equity | -233.50M | -230.80M | -180.40M | -165.50M | -103.70M | -84.30M |
Cash Flow | ||||||
| Free Cash Flow | 106.00M | 120.50M | -9.90M | 8.10M | -30.20M | 65.40M |
| Operating Cash Flow | 141.20M | 146.60M | 9.10M | 26.50M | -9.50M | 89.50M |
| Investing Cash Flow | -33.00M | -22.60M | -13.90M | 23.20M | -22.50M | -299.20M |
| Financing Cash Flow | -51.60M | -61.20M | -26.50M | -49.40M | 68.10M | 17.80M |
INNOVATE Corp Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VATE, the sentiment is Negative. The current price of 5.48 is below the 20-day moving average (MA) of 6.18, below the 50-day MA of 6.97, and below the 200-day MA of 8.94, indicating a bearish trend. The MACD of -0.47 indicates Positive momentum. The RSI at 29.86 is Positive, neither overbought nor oversold. The STOCH value of 21.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VATE.
INNOVATE Corp Risk Analysis
INNOVATE Corp disclosed 87 risk factors in its most recent earnings report. INNOVATE Corp reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksINNOVATE Corp Peers Comparison
Overall Rating
ESOA65Neutral- VATE61Neutral
SUNE45.2Neutral
SHIM45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ESOA | 65Neutral | $175.40M | 14.99 | 14.64% | 1.55% | 21.21% | 252.85% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| VATE | 61Neutral | $75.17M | -2.92 | 9.58% | ― | 52.38% | 70.10% |
| SUNE | 45Neutral | $13.35M | -1.94 | -24.03% | ― | 10.34% | 99.97% |
| SHIM | 45Neutral | $103.75M | -5.42 | 30.27% | ― | -15.98% | 73.32% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VATE | INNOVATE Corp | 5.38 | -0.22 | -3.93% | |
| SUNE | Sunation Energy, Inc. | 2.10 | 0.76 | 56.72% | |
| ESOA | Energy Services Of America | 9.03 | -1.61 | -15.16% | |
| SHIM | Shimmick Corporation | 2.51 | 0.22 | 9.61% |
INNOVATE Corp Corporate Events
INNOVATE Corp amends 2027 convertible notes redemption terms
PositiveINNOVATE Corp. has entered into a supplemental indenture amending the terms of its 9.500% Convertible Senior Secured Notes due 2027, in connection with the stock consideration it received from the sale of DBMG Global Inc. The amendment requires that...
INNOVATE Corp Sells DBM Global, Accelerates Debt Reduction
PositiveOn October 5, 2026, INNOVATE Corp. completed the sale of its majority-owned subsidiary DBM Global, Inc. to IES Holdings, Inc., transferring 100% of DBMG’s shares, including approximately 91.21% previously held through DBM Global Intermediate Ho...
INNOVATE Corp completes HC2 stake sale and recapitalization
PositiveOn August 28, 2026, INNOVATE Corp. executed a tenth amendment to its credit agreement with MSD PCOF Partners IX, LLC, extending the maturity of its existing facility to December 31, 2026, reinforcing near-term financing flexibility. On September 1, 2...
MediBeacon’s Kidney Diagnostic Platform Nominated for Prix Galien
PositiveMediBeacon’s TGFR System, which uses the Lumitrace (relmapirazin) fluorescent tracer, a monitor and reusable sensor to deliver point-of-care transdermal kidney function measurements, has been nominated by The Galien Foundation for the 2026 Prix...
INNOVATE Launches ATM Equity Program to Bolster Liquidity
NeutralOn August 7, 2026, INNOVATE Corp agreed to sell its approximately 91.21% stake in DBM Global Inc. to IES Holdings Inc., as part of a $650 million cash-and-stock transaction for 100% of DBMG. The deal, expected to close in the quarter ending December...
INNOVATE Corp Posts Strong Q2 Results, Refocuses Portfolio
PositiveINNOVATE Corp. reported strong consolidated results for the second quarter ended June 30, 2026, with revenue rising to $421.6 million from $242.0 million a year earlier and net income attributable to common stockholders improving to $10.4 million fro...
INNOVATE Corp Adopts PIK Interest to Bolster Liquidity
PositiveOn July 31, 2026, INNOVATE Corp. executed supplemental indentures on its 10.500% Senior Secured Notes due 2027 and 9.5% Convertible Senior Secured Notes due 2027, allowing consenting holders to receive interest from February 1, 2026 through July 31,...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 10, 2026